The aim is aspirational: Hospital executives shouldn’t make more than the president of the United States.
Mirum’s maralixibat oral secures approval from Health Canada
LIVMARLI has been now authorised in Canada to treat cholestatic pruritus in patients with Alagille syndrome. Credit: Shidlovski /Shutterstock.com. Mirum Pharmaceuticals has received approval from